Abilify

In the US, Abilify (aripiprazole systemic) is a member of the drug class atypical antipsychotics and is used to treat Agitated State, Autism, Bipolar Disorder, Depression, Obsessive Compulsive Disorder, Post Traumatic Stress Disorder, Schizoaffective Disorder, Schizophrenia and Tourette's Syndrome.

US matches:

• Abilify


• Abilify Discmelt Orally Disintegrating Tablets


• Abilify Solution


• Abilify Tablets


• Abilify Discmelt


• Abilify Intramuscular

UK matches:

• Abilify 7.5 mg/ml solution for injection (intramuscular) (Bristol-Myers Squibb Pharmaceuticals Ltd) (SPC)
• Abilify Tablets, Orodispersible Tablets, Oral Solution (Otsuka & Bristol-Myers Squibb) (SPC)

Ingredient matches for Abilify

Aripiprazole

Aripiprazole is reported as an ingredient of Abilify in the following countries:

• Australia


• Austria


• Bahrain


• Belgium


• Brazil


• Bulgaria


• Chile


• Colombia


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Ireland


• Italy


• Japan


• Luxembourg


• Mexico


• Netherlands


• New Zealand


• Norway


• Oman


• Peru


• Philippines


• Portugal


• Romania


• Russian Federation


• Singapore


• Slovakia


• South Africa


• Spain


• Sweden


• Switzerland


• Thailand


• Tunisia


• Turkey


• United Kingdom


• United States


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.